Bandaram Pharma

Market Cap: Micro Cap
Industry: Medical Equipment/Supplies/Accessories
ISIN: INE875N01036
NSEID:
BSEID: 524602

INR

37.29

1.43 (3.99%)

BSENSE

Apr 11, 12:41 PM

BSE+NSE Vol: 279

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Blue Jet Health

Vimta Labs

Poly Medicure

Bandaram Pharma

Shree Pacetronix

Span Divergent

Laxmi Dental

KMS Medisurgi

Amkay Products

Adeshwar Meditex

MOS Utility

Why is Bandaram Pharma Packtech Ltd ?

High Debt company with Weak Long Term Fundamental Strength

High Debt Company with a Debt to Equity ratio (avg) at 0 times
The company has been able to generate a Return on Equity (avg) of 8.09% signifying low profitability per unit of shareholders funds

Flat results in Dec 24

EPS(Q) Lowest at Rs -0.01

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Sideways on 07-Apr-25 and has generated -15.44% returns since then
The stocks MACD and Bollinger Band technical factors are also Bearish

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Medical Equipment/Supplies/Accessories)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Bandaram Pharma for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Bandaram Pharma

6.42%

0.11

60.81%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

82.00%

EBIT Growth (5y)

152.00%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.01%

ROCE (avg)

57.36%

ROE (avg)

8.09%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.27

EV to EBIT

27.52

EV to EBITDA

20.40

EV to Capital Employed

2.08

EV to Sales

1.69

PEG Ratio

Dividend Yield

0.05%

ROCE (Latest)

7.56%

ROE (Latest)

7.22%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET SALES(9M)

At Rs 28.48 cr has Grown at 36.46%

PAT(9M)

Higher at Rs 0.84 Cr

-1What is not working for the Company

EPS(Q)

Lowest at Rs -0.01

Loading Valuation Snapshot...

Here's what is working for Bandaram Pharma

Profit After Tax (PAT) - Half Yearly

Higher at Rs 0.66 cr

than preceding 12 month period ended Dec 2024 of Rs 0.55 cr

MOJO Watch

In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Net Sales - Quarterly

At Rs 10.00 cr has Grown at 35.87%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Bandaram Pharma

Earnings per Share (EPS) - Quarterly

Lowest at Rs -0.01

in the last five quarters

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (Rs)